Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Jeanne Thoma Insider Profile
4 Followers
Jeanne Thoma, Director at ANI Pharmaceuticals, holds 0.00 shares in Avid Bioservices (Ticker: CDMO), holds 40.61K shares in ANI Pharmaceuticals (Ticker: ANIP).
Jeanne Thoma has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Roles
Director
Roles that Jeanne Thoma holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Dec 22, 2021 - Dec 22, 2022
Return:-19.60%
The most profitable trade made by Jeanne Thoma
Jeanne Thoma's Trading History
ANI Pharmaceuticals
May 23, 2024
Director
Uninformative Buy
―
$2.35M
Avid Bioservices
Feb 07, 2025
―
Uninformative Sell
―
$0.00
List of latest transactions for each holding click on a transaction to see Jeanne Thoma's performance on stock
You May Also Like
Jeanne Thoma insider profile FAQ
What is the percentage of profitable transactions made by Jeanne Thoma?
The percentage of profitable transactions made by Jeanne Thoma is ―.
What is the average return per transaction made by Jeanne Thoma?
The average return per transaction made by Jeanne Thoma is ―.
What stocks does Jeanne Thoma hold?
Jeanne Thoma holds: ANIP, CDMO stocks.
What was Jeanne Thoma’s latest transaction?
Jeanne Thoma latest transaction was an Uninformative Sell of ―.
What was Jeanne Thoma's most profitable transaction?
Jeanne Thoma’s most profitable transaction was an Informative Buy of ANIP stock on December 22, 2021. The return on the trade was -19.60%.
What is Jeanne Thoma's role in ANI Pharmaceuticals?
Jeanne Thoma's role in ANI Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.